AI주식인사이트AI Stock Insight
C

HLB

028300KOSDAQ

52.6 / 100

Reference Date: 2026-09-08

Financial Score17.0 / 40
News Sentiment17.6 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 11.7% over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

HLB operates in four key sectors: healthcare, biotechnology, shipbuilding, and media commerce. The company produces and sells a range of products, including in-vitro diagnostic medical devices, oncology drugs like Rivoceranib and RLY-4008, specialty ships, and beauty devices. In the biotechnology sector, the company focuses on innovative drug development, while the shipbuilding division designs and manufactures specialty vessels and safety equipment.

Number of Employees

151people

Average Salary

60.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
8.88Industry Average 1.200.0Point

7.4x industry avg (risky)

ROE
-41.07Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
17.82Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲41.2% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -30.1% (declining, 3yr)

Detailed News Sentiment

41 totalPositive 17Neutral 6Negative 18Average Sentiment Score 70.2

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 32,950Won52-week high 68,20052-week low 25,650
1-month return1.0Point

1m -11.66% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-09-07
  • Neutral전환가액의조정2026-08-28
  • Neutral주식등의대량보유상황보고서(일반)2026-08-20
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-20
  • Neutral증권발행결과(자율공시)2026-08-19